All Stories

  1. Contrast‐Enhanced Ultrasound: The Case for a Whole‐Body Indication—An Expert Panel Discussion
  2. Diagnostic Accuracy of Quantitative Ultrasound Liver Fat Estimation with MRI ‐ PDFF as the Reference Standard
  3. CEUS LI-RADS Accuracy in Chronic Liver Disease Due to Liver Congestion
  4. Letter to the Editor for Hawley et al. UMB 2025:51(3);415-427
  5. EFSUMB Guidelines on Multiparametric Ultrasound Thyroid Nodule Evaluation: PART I
  6. EFSUMB Guidelines on Multiparametric Ultrasound Thyroid Nodule Evaluation: PART II
  7. Overview of Diagnostic Ultrasound Safety
  8. Optimization of measurements with an ultrasound attenuation coefficient algorithm for quantifying liver fat
  9. Invited Commentary: Ancillary US of the Bowel for Improved Patient Care and Management
  10. Deep Learning Model for Breast Shear Wave Elastography to Improve Breast Cancer Diagnosis (INSPiRED 006): An International, Multicenter Analysis
  11. A Nurses Guide to Contrast Enhanced Ultrasound
  12. The State of the Journal of Ultrasound in Medicine in 2024
  13. US Screening for Liver Lesions in Patients at Risk for HCC: How Well Does LI-RADS US Scoring System Perform?
  14. Intersystem and Interoperator Agreement of US Attenuation Coefficient for Quantifying Liver Steatosis
  15. Assessing Quality of Ultrasound Attenuation Coefficient Results for Liver Fat Quantification
  16. Ultrasound evaluation of chronic liver disease
  17. Letter to the Editor: “Altered probe pressure and body position increase diagnostic accuracy for men and women in detecting hepatic steatosis using quantitative ultrasound”
  18. Ultrasound backscatter coefficient for fat quantification is affected by the measurement depth
  19. Evaluation of Liver Stiffness Values Requires Consideration of Many Factors
  20. Contrast-enhanced US for HCC: Finally out from the waiting list?
  21. Breast elastography: how does it works, and for what purposes?
  22. Contrast-enhanced ultrasound: the ideal contrast imaging study for pregnant patients
  23. Toward acquisition protocol standardization for estimating liver fat content using ultrasound attenuation coefficient imaging
  24. Liver Fibrosis, Fat, and Iron Evaluation with MRI and Fibrosis and Fat Evaluation with US: A Practical Guide for Radiologists
  25. Screening for Hepatocellular Carcinoma:Image Quality Is Everything!
  26. State of the Journal: The JUM in 2022
  27. Liver Fat Quantification With Ultrasound
  28. New Technologies in the Assessment of Carotid Stenosis: Beyond the Color-Doppler Ultrasound—High Frame Rate Vector-Flow and 3D Arterial Analysis Ultrasound
  29. Ultrasound shear wave elastography for the evaluation of renal pathological changes in adult patients
  30. Potential of Lesion‐to‐Fat Elasticity Ratio Measured by Shear Wave Elastography to Reduce Benign Biopsies in BI‐RADS 4 Breast Lesions
  31. Long‐Term Follow‐Up of Non‐Enhancing Renal Masses on CEUS
  32. Deep learning‐based multimodal fusion network for segmentation and classification of breast cancers using B‐mode and elastography ultrasound images
  33. Interpreting Liver Stiffness Values in Clinical Practice: Is Histologic Classification Necessary for Clinical Relevance?
  34. Intelligent multi-modal shear wave elastography to reduce unnecessary biopsies in breast cancer diagnosis (INSPiRED 002): a retrospective, international, multicentre analysis
  35. Editorial Comment: How Imaging Can Manage the Fatty Liver Epidemic
  36. Shear wave elastography as a supplemental tool in the assessment of unsuspicious axillary lymph nodes in patients undergoing breast ultrasound examination
  37. Increasing CEUS utilization in the USA: a call to action for the adult and pediatric body imaging community
  38. Nebulizer use in tobacco-exposed SPIROMICS participants with or at risk of COPD
  39. Quantitative CT emphysema subtypes and pulmonary blood volume on dual-energy CT: The MESA Lung Study
  40. Race/ethnic, social, environmental, and genetic correlates to lung function decline: the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study
  41. The Urgent Need for FDA to Approve a Whole‐Body Application of Ultrasound Contrast Agents
  42. State of the Journal 2022
  43. US-targeted Microbubbles to Assess Liver Fibrosis
  44. Contrast Enhanced Ultrasound Compared with MRI and CT in the Evaluation of Post-Renal Transplant Complications
  45. How to perform shear wave elastography. Part II
  46. Diagnostic Accuracy of Shear-Wave Elastography for Breast Lesion Characterization in Women: A Systematic Review and Meta-Analysis
  47. US Attenuation for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative
  48. The importance of multi-modal imaging and clinical information for humans and AI-based algorithms to classify breast masses (INSPiRED 003): an international, multicenter analysis
  49. How to perform shear wave elastography. Part I
  50. Abstract PD11-05: Intelligent shear-wave elastography to reduce unnecessary biopsies in breast cancer diagnosis (INSPiRED 002): An international, multicenter analysis
  51. Bi-Modal Transfer Learning for Classifying Breast Cancers via Combined B-Mode and Ultrasound Strain Imaging
  52. The potential of combined shear wave and strain elastography to reduce unnecessary biopsies in breast cancer diagnostics – An international, multicentre trial
  53. Reasons why referring doctors order renal ultrasound contrast studies
  54. Outcomes of Return to Routine Screening for BI-RADS 3 Lesions Detected at Supplemental Automated Whole-Breast Ultrasound in Women With Dense Breasts: A Prospective Study
  55. A Pre‐Release Algorithm With a Confidence Map for Estimating the Attenuation Coefficient for Liver Fat Quantification
  56. Ocular Ultrasound
  57. Use of lumason/sonovue in contrast-enhanced ultrasound of the kidney for characterization of renal masses—a meta-analysis
  58. Quantification of Liver Fat Content with Ultrasound: A WFUMB Position Paper
  59. Your “Sweet Spot” May Not Be So Sweet for Me
  60. The Potential of Shear Wave Elastography to Reduce Unnecessary Biopsies in Breast Cancer Diagnosis: An International, Diagnostic, Multicenter Trial
  61. Assessment of chronic liver disease by multiparametric ultrasound: results from a private practice outpatient facility
  62. Conventional ultrasound for diagnosis of hepatic steatosis is better than believed
  63. Dose‐Lowering in Contrast‐Enhanced MRI of the Central Nervous System: A Retrospective, Parallel‐Group Comparison Using Gadobenate Dimeglumine
  64. First proof-of-concept evaluation of the FUSION-X-US-II prototype for the performance of automated breast ultrasound in healthy volunteers
  65. A New Practical Decision Rule to Better Differentiate BI‐RADS 3 or 4 Breast Masses on Breast Ultrasound
  66. Are Race and Ethnicity Necessary to Define 'Normal' Lung Function? The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study
  67. Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort
  68. Quantification of Liver Steatosis: Is CT Equivalent to PDFF?
  69. The Underrated Role of Ultrasound in Peritoneal Dialysis
  70. First Proof-of-concept Evaluation of the FUSION-X-US-II Prototype for the Performance of Automated Breast Ultrasound in Healthy Volunteers
  71. Editor's Letter: State of the Journal
  72. Radiological Society of North America/Quantitative Imaging Biomarker Alliance Shear Wave Speed Bias Quantification in Elastic and Viscoelastic Phantoms
  73. Characterisation of Prostate Lesions Using Transrectal Shear Wave Elastography (SWE) Ultrasound Imaging: A Systematic Review
  74. Evaluation of the FUSION-X-US-II prototype to combine automated breast ultrasound and tomosynthesis
  75. Novel Approaches to Screening for Breast Cancer
  76. Genetic and non-genetic factors affecting the expression of COVID-19 relevant genes in the large airway epithelium
  77. Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver–Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS
  78. Elastography for Pediatric Chronic Liver Disease: A Review and Expert Opinion
  79. Contrast-enhanced Ultrasound—State of the Art in North America
  80. Contrast -Enhanced Ultrasound
  81. Contrast-Enhanced Ultrasonography of the Abdomen
  82. Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement
  83. Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2020 – WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS
  84. Evaluation of the Reproducibility of Bolus Transit Quantification With Contrast-Enhanced Ultrasound Across Multiple Scanners and Analysis Software Packages—A Quantitative Imaging Biomarker Alliance Study
  85. Prediction of pathological complete response in breast cancer patients during neoadjuvant chemotherapy: Is shear wave elastography a useful tool in clinical routine?
  86. Ultrasound liver elastography beyond liver fibrosis assessment
  87. Contrast-enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and Sonazoid
  88. Characterization and clinical course of 1000 patients with COVID-19 in New York: retrospective case series
  89. Advanced ultrasound in the diagnosis of prostate cancer
  90. Benefits, Open questions and Challenges of the use of Ultrasound in the COVID-19 pandemic era. The views of a panel of worldwide international experts
  91. Abstract P151: Race/ethnic Differences in Six Minute Walk Distance Among Older Adults: The Multi-ethnic Study of Atherosclerosis
  92. AIUM Practice Parameter for the Performance of Contrast‐Enhanced Ultrasound Examinations
  93. Breast elastography
  94. Can Accurate Shear Wave Velocities Be Obtained in Kidneys?
  95. Breast Elastography: How to Perform and Integrate Into a “Best‐Practice” Patient Treatment Algorithm
  96. 2-D Shear wave dispersion images using the reverberant shear wave field approach: application in tissues exhibiting power law response
  97. An initial study of complete 2D shear wave dispersion images using a reverberant shear wave field
  98. Letter to the Editor
  99. Ultrasound of Diffuse Liver Disease Including Elastography
  100. Use of a Real‐Time Stress Map for Assessment of Applied Stress for Strain Elastography: Utility in Training and Computation of Strain Ratios
  101. Future of breast elastography
  102. Just Because There is a Button Doesn't Mean it is Appropriate to Use or That it will Give Accurate Information
  103. A Clinical Study Comparing the Diagnostic Performance of Assist Strain Ratio Against Manual Strain Ratio in Ultrasound Breast Elastography
  104. Passing of the Transducer
  105. Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations
  106. Diagnostic Performance and Accuracy of the 3 Interpreting Methods of Breast Strain Elastography: A Systematic Review and Meta‐analysis
  107. Editorial Comment
  108. Gastric Lipoma
  109. Liver Elastography Still in Its Infancy
  110. Initial results of the FUSION-X-US prototype combining 3D automated breast ultrasound and tomosynthesis
  111. Evaluation of Inter-System Variability in Liver Stiffness Measurements
  112. Focal Liver Lesions: Computer-aided Diagnosis by Using Contrast-enhanced US Cine Recordings
  113. Contrast-Enhanced Ultrasound-Guided Radiofrequency Ablation of Renal Tumo
  114. The Role of Sonoelastography in Breast Lesions
  115. Initial results of the FUSION-X-US prototype combining 3D automated breast ultrasound and digital breast tomosynthesis
  116. How to perform Contrast-Enhanced Ultrasound (CEUS)
  117. Artifacts in contrast-enhanced ultrasound: a pictorial essay
  118. Shear wave liver elastography
  119. Strain Elastography - How To Do It?
  120. Contrast enhanced ultrasound for focal liver lesions: how accurate is it?
  121. Agreement Between an Automated Volume Breast Scanner and Handheld Ultrasound for Diagnostic Breast Examinations
  122. Thyroid Ultrasound: State of the Art. Part 2 – Focal Thyroid Lesions
  123. Ultrasound Elastography of the Liver: What the Clinician Needs to Know
  124. A Case Study of Hemochromatosis and Conflicting Point Shear Wave Measurements in the Assessment of Liver Fibrosis
  125. Primary Angiosarcoma of the Breast
  126. How to Develop a Contrast-Enhanced Ultrasound Program
  127. Thyroid Ultrasound: State of the Art Part 1 – Thyroid Ultrasound reporting and Diffuse Thyroid Diseases
  128. Is There a Need to Modify the Bosniak Renal Mass Classification With the Addition of Contrast-Enhanced Sonography?
  129. Foreword to the Second Set of WFUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography
  130. WFUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography: Part 4. Thyroid
  131. WFUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography: Part 5. Prostate
  132. Compression with transducer effects breast blood flow
  133. Invited Commentary on “Elastography in Chronic Liver Disease”
  134. Sonoelastography of Breast Lymphoma
  135. Sonographic Elastography of Mastitis
  136. Elastography Assessment of Liver Fibrosis
  137. Richard G Barr. Breast ElastographyBarrRichard G. Breast Elastography. New York, USA: Thieme Medical Publishers Inc, 2015. ISBN: 9781604068528; 192 pp.: £68.50 (hbk)
  138. Consensus on Elastography of the Liver
  139. Transcutaneous Ultrasound: Elastographic Lymph Node Evaluation. Current Clinical Applications and Literature Review
  140. RSNA QIBA ultrasound shear wave speed Phase II phantom study in viscoelastic media
  141. Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement
  142. WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 2: Breast
  143. WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 3: Liver
  144. WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 1: Basic Principles and Terminology
  145. Prostate Cancer: Diagnostic Performance of Real-time Shear-Wave Elastography
  146. Shear-Wave Elastography of the Breast: Value of a Quality Measure and Comparison with Strain Elastography
  147. Clinical application of sonoelastography in thyroid, prostate, kidney, pancreas, and deep venous thrombosis
  148. Breast Elastography
  149. 2 elastographyPrinciples of Elastography
  150. 1 -elastographyIntroduction to Breast Elastography
  151. 3 strain elastography (SE)Strain Elastography
  152. 4 shear wave elastography (SWE)Shear Wave Elastography
  153. 6 benign lesionsClinical Cases: Benign Lesions
  154. 7 malignant lesionsClinical Cases: Malignant Lesions
  155. 8 lesionsClinical Cases of Other Lesions
  156. 9 elastographyFuture Perspective and Conclusions
  157. 5 strain elastography (SE)combined with shear wave elastographyshear wave elastography (SWE)combined with strain elastographyCombination of Shear Wave and Strain Elastography
  158. Breast Elastography
  159. Elastography in Clinical Practice
  160. Elastography of the Abdomen
  161. Evaluation of Indeterminate Renal Masses with Contrast-enhanced US: A Diagnostic Performance Study
  162. Incidental Detection of an Aortic Stent Endoleak With Contrast-Enhanced Sonography
  163. Strain Elastography for Prediction of Breast Cancer Tumor Grades
  164. Probably Benign Lesions at Screening Breast US in a Population with Elevated Risk: Prevalence and Rate of Malignancy in the ACRIN 6666 Trial
  165. US Elastography: Applications in Tumors
  166. Lung Cancer Metastatic to Breast
  167. RSNA/QIBA: Shear wave speed as a biomarker for liver fibrosis staging
  168. Artifacts in diagnostic ultrasound
  169. Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2012
  170. Off-Label Use of Ultrasound Contrast Agents for Abdominal Imaging in the United States
  171. Contrast-Enhanced Ultrasound-Guided Radiofrequency Ablation of Renal Tumors
  172. Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2012
  173. Speed of Sound Correction and Quality Control
  174. Supplementary Imaging for Breast Cancer Screening in High-Risk Women—Reply
  175. Improved Needle Visualization With Electronic Beam Steering
  176. Effects of Precompression on Elasticity Imaging of the Breast
  177. Sonographic Breast Elastography
  178. Detection of Breast Cancer With Addition of Annual Screening Ultrasound or a Single Screening MRI to Mammography in Women With Elevated Breast Cancer Risk
  179. Shear Wave Ultrasound Elastography of the Prostate
  180. Shear Wave Imaging of the Breast
  181. The Utility of the “Bull’s-Eye” Artifact on Breast Elasticity Imaging in Reducing Breast Lesion Biopsy Rate
  182. Evaluation of Breast Lesions Using Sonographic Elasticity Imaging
  183. The Utility of the "Bull's-Eye" Artifact on Breast Elasticity Imaging in Reducing Breast Lesion Biopsy Rate
  184. Mesothelioma of tunica vaginalis of "uncertain malignant potential" - an evolving concept: case report and review of the literature
  185. Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial
  186. The National Lung Screening Trial: Overview and Study Design
  187. Real-Time Ultrasound Elasticity of the Breast
  188. Reasons Women at Elevated Risk of Breast Cancer Refuse Breast MR Imaging Screening: ACRIN 6666
  189. Contrast-Enhanced Ultrasound Detection and Treatment Guidance in a Renal Transplant Patient With Renal Cell Carcinoma
  190. US Elastography of Breast and Prostate Lesions1
  191. Comparison of Conventional, Compounding, Computer Enhancement, and Compounding With Computer Enhancement in Ultrasound Imaging of the Breast
  192. Comparison of Sonography and Scintigraphy in the Evaluation of Gallbladder Functional Studies With Cholecystokinin
  193. Speed of Sound Imaging
  194. Dynamic Automatic Ultrasound Optimization
  195. Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer
  196. Meta-analysis of laparoscopic and open distal gastrectomy for gastric carcinoma
  197. Duplex Doppler Sonography of the Carotid Artery
  198. In situ measurements of orange roughy (Hoplostethus atlanticus) target strength
  199. Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity
  200. Renal imaging with ultrasound contrast
  201. Gastroesophageal reflux disease (GERD) and asthma in women
  202. Seeking Consensus
  203. Seeking consensus: contrast ultrasound in radiology
  204. A Clinical Comparison of the Safety and Efficacy of MultiHance (Gadobenate Dimeglumine) and Omniscan (Gadodiamide) in Magnetic Resonance Imaging in Patients with Central Nervous System Pathology
  205. Evaluation of Renal Pathology With an Intravenous Ultrasound Contrast Agent
  206. Significance of Minimal or No Intraperitoneal Fluid Visible on CT Scan Associated with Blunt Liver and Splenic Injuries: A Multicenter Analysis
  207. Contrast-Enhanced Sonography in Patients with Renal Pathology
  208. Pharmacokinetics, safety, and tolerability of gadoversetamide injection (OptiMARK) in subjects with central nervous system or liver pathology and varying degrees of renal function
  209. Run-in Periods in Randomized Trials
  210. ELF and VLF wave generation by HF heating: A comparison of AM and CW techniques
  211. Acalculous gallbladder disease: US evaluation after slow-infusion cholecystokinin stimulation in symptomatic and asymptomatic adults.
  212. Nonadherence in Tuberculosis Treatment: Predictors and Consequences in New York City
  213. Reflection of VLF radio waves from the Canadian Rockies
  214. Ethidium Bromide Binding to Unstructured and Structured 2′ GMP
  215. A simple theoretical model for computing omega navigation errors near Antarctica
  216. Extracorporeal liver and spleen in gastroschisis.
  217. Structure Sensitivity of Amino Proton Exchange in 2′ - and 5′ - Guanosine Monophosphate Dianions
  218. Collaborative experiments by Akebono satellite, Tromsø ionospheric heater, and European incoherent scatter radar
  219. A simple theoretical model of the diffraction of VLF electromagnetic waves by the Antarctic icecap
  220. Proton NMR imaging of cerebral blood flow using H217O
  221. The stability of protonT2 effects of oxygen-17 water in experimental cerebral ischemia
  222. Bilateral renal masses in a 61-year-old man
  223. Renal tissue within the adrenal gland simulating an adrenal mass.
  224. Oxygen-17 Contrast Agents Fast Imaging Techniques
  225. Oxygen-17 Contrast Agents Fast Imaging Techniques
  226. Improved sensitivity of proton MR to oxygen-17 as a contrast agent using fast imaging: Detection in brain
  227. Physiological Application of17O Promoted Proton T2Relaxation
  228. Oxygen-17 compounds as potential NMRT2 contrast agents: Enrichment effects of H217O on protein solutions and living tissues
  229. The significance of fast imaging methods to oxygen-17 based contrast agents
  230. Solution ordering of guanosine 2'-monophosphate dianions with alkali metal ions as structure directors
  231. Fasting breath hydrogen concentration: Normal values and clinical application
  232. Ordered forms of dianionic guanosine 5'-monophosphate with sodium ion as the structure director. Proton and phosphorus-31 NMR studies of hydrogen bonding and comparisons of stacked tetramer and stacked dimer models
  233. 31P NMR studies of energy metabolism in perfused rat kidney
  234. Some new features of ELF attenuation
  235. The effect of the Earth's magnetic field on the propagation of ELF and VLF radio waves
  236. The propagation of ELF and VLF radio waves beneath an inhomogeneous anisotropic ionosphere
  237. The attenuation of ELF and VLF radio waves propagating below inhomogeneous isotropic ionospheres
  238. The ELF and VLF amplitude spectrum of atmospherics with particular reference to the attenuation band near 3 kHz
  239. POLLY I: Operator‐Assisted Bubble Chamber Film Measuring System